MedTrace Logo

Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

NCT05723653 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2026-04-08

No results posted yet for this study

Summary

The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.

Conditions

  • HIV Seropositivity

Interventions

BEHAVIORAL

Social Network Support Intervention

The Social Network Support Intervention is an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV. The intervention consists of (1) selection and invitation of a Support Confidant, (2) a face-to-face intervention between the Intervention Case Manager and the Index and Support Confidant, and (3) quarterly interactive mini-booster sessions delivered to the Index and Support Confidant via text or telephone, based on participant preference.

Sponsors & Collaborators

  • Tulane University

    collaborator OTHER

  • University of Alabama at Birmingham

    collaborator OTHER

  • Birmingham AIDS Outreach

    collaborator UNKNOWN

  • Chicago Center for HIV Elimination

    collaborator UNKNOWN

  • Howard Brown Health

    collaborator UNKNOWN

  • Thrive Alabama

    collaborator UNKNOWN

  • University of Chicago

    lead OTHER

Principal Investigators

  • Alida Bouris, PhD · University of Chicago

  • David S Batey, PhD · Tulane University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-13
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05723653 on ClinicalTrials.gov